# Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

> **NCT01642017** · PHASE1 · TERMINATED · sponsor: **Institut Claudius Regaud** · enrollment: 18 (actual)

## Conditions studied

- Metastatic Cancer (Different Solid Tumour Types)

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT01642017
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-22
- **Primary completion:** 2017-09
- **Final completion:** 2018-03
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Slow recruitment rate
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642017, "Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01642017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*